nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxycodone—CYP2D6—Lomustine—brain cancer	0.173	0.271	CbGbCtD
Oxycodone—CYP2D6—Hydroxyurea—brain cancer	0.131	0.205	CbGbCtD
Oxycodone—CYP3A4—Temozolomide—brain cancer	0.129	0.203	CbGbCtD
Oxycodone—CYP3A4—Lomustine—brain cancer	0.11	0.172	CbGbCtD
Oxycodone—CYP3A5—Etoposide—brain cancer	0.0682	0.107	CbGbCtD
Oxycodone—CYP3A4—Etoposide—brain cancer	0.0266	0.0416	CbGbCtD
Oxycodone—OPRM1—telencephalic ventricle—brain cancer	0.00598	0.149	CbGeAlD
Oxycodone—OPRD1—ganglion—brain cancer	0.00546	0.136	CbGeAlD
Oxycodone—OPRM1—ganglion—brain cancer	0.00373	0.0928	CbGeAlD
Oxycodone—OPRD1—telencephalon—brain cancer	0.00211	0.0525	CbGeAlD
Oxycodone—OPRM1—brainstem—brain cancer	0.00162	0.0404	CbGeAlD
Oxycodone—OPRM1—telencephalon—brain cancer	0.00144	0.0358	CbGeAlD
Oxycodone—CYP3A7—endocrine gland—brain cancer	0.0014	0.0348	CbGeAlD
Oxycodone—OPRD1—head—brain cancer	0.00131	0.0327	CbGeAlD
Oxycodone—OPRK1—head—brain cancer	0.00126	0.0313	CbGeAlD
Oxycodone—OPRD1—central nervous system—brain cancer	0.0012	0.0298	CbGeAlD
Oxycodone—OPRK1—central nervous system—brain cancer	0.00115	0.0286	CbGeAlD
Oxycodone—CYP2D6—hindbrain—brain cancer	0.00113	0.0282	CbGeAlD
Oxycodone—OPRK1—cerebellum—brain cancer	0.00112	0.028	CbGeAlD
Oxycodone—OPRM1—midbrain—brain cancer	0.00103	0.0257	CbGeAlD
Oxycodone—OPRM1—spinal cord—brain cancer	0.00101	0.0251	CbGeAlD
Oxycodone—OPRD1—brain—brain cancer	0.000951	0.0237	CbGeAlD
Oxycodone—OPRK1—brain—brain cancer	0.000912	0.0227	CbGeAlD
Oxycodone—OPRM1—endocrine gland—brain cancer	0.000906	0.0226	CbGeAlD
Oxycodone—OPRM1—head—brain cancer	0.000895	0.0223	CbGeAlD
Oxycodone—OPRM1—central nervous system—brain cancer	0.000817	0.0204	CbGeAlD
Oxycodone—Urinary tract infection—Carmustine—brain cancer	0.000755	0.00236	CcSEcCtD
Oxycodone—Pneumonia—Temozolomide—brain cancer	0.000755	0.00236	CcSEcCtD
Oxycodone—Anorexia—Procarbazine—brain cancer	0.000755	0.00236	CcSEcCtD
Oxycodone—Infestation NOS—Temozolomide—brain cancer	0.000751	0.00235	CcSEcCtD
Oxycodone—Infestation—Temozolomide—brain cancer	0.000751	0.00235	CcSEcCtD
Oxycodone—Cardiac arrest—Etoposide—brain cancer	0.000741	0.00232	CcSEcCtD
Oxycodone—Nausea—Lomustine—brain cancer	0.000741	0.00232	CcSEcCtD
Oxycodone—Hypotension—Procarbazine—brain cancer	0.00074	0.00231	CcSEcCtD
Oxycodone—Stomatitis—Temozolomide—brain cancer	0.000732	0.00229	CcSEcCtD
Oxycodone—Urinary tract infection—Temozolomide—brain cancer	0.00073	0.00228	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000721	0.00226	CcSEcCtD
Oxycodone—Insomnia—Procarbazine—brain cancer	0.000716	0.00224	CcSEcCtD
Oxycodone—Paraesthesia—Procarbazine—brain cancer	0.000711	0.00222	CcSEcCtD
Oxycodone—Hepatobiliary disease—Temozolomide—brain cancer	0.00071	0.00222	CcSEcCtD
Oxycodone—Sinusitis—Temozolomide—brain cancer	0.000704	0.0022	CcSEcCtD
Oxycodone—Somnolence—Procarbazine—brain cancer	0.000704	0.0022	CcSEcCtD
Oxycodone—Haemoglobin—Carmustine—brain cancer	0.000701	0.00219	CcSEcCtD
Oxycodone—Haemorrhage—Carmustine—brain cancer	0.000697	0.00218	CcSEcCtD
Oxycodone—Ill-defined disorder—Hydroxyurea—brain cancer	0.000697	0.00218	CcSEcCtD
Oxycodone—Anaemia—Hydroxyurea—brain cancer	0.000694	0.00217	CcSEcCtD
Oxycodone—Hallucination—Carmustine—brain cancer	0.000694	0.00217	CcSEcCtD
Oxycodone—Hypoaesthesia—Carmustine—brain cancer	0.000694	0.00217	CcSEcCtD
Oxycodone—Decreased appetite—Procarbazine—brain cancer	0.000688	0.00215	CcSEcCtD
Oxycodone—Oedema peripheral—Carmustine—brain cancer	0.000687	0.00215	CcSEcCtD
Oxycodone—Connective tissue disorder—Carmustine—brain cancer	0.000685	0.00214	CcSEcCtD
Oxycodone—Fatigue—Procarbazine—brain cancer	0.000683	0.00213	CcSEcCtD
Oxycodone—Haemoglobin—Temozolomide—brain cancer	0.000677	0.00212	CcSEcCtD
Oxycodone—Malaise—Hydroxyurea—brain cancer	0.000677	0.00212	CcSEcCtD
Oxycodone—Pain—Procarbazine—brain cancer	0.000677	0.00212	CcSEcCtD
Oxycodone—Constipation—Procarbazine—brain cancer	0.000677	0.00212	CcSEcCtD
Oxycodone—Haemorrhage—Temozolomide—brain cancer	0.000674	0.00211	CcSEcCtD
Oxycodone—Hepatitis—Temozolomide—brain cancer	0.000674	0.00211	CcSEcCtD
Oxycodone—Dysphagia—Etoposide—brain cancer	0.000674	0.00211	CcSEcCtD
Oxycodone—Leukopenia—Hydroxyurea—brain cancer	0.000672	0.0021	CcSEcCtD
Oxycodone—Visual impairment—Carmustine—brain cancer	0.000672	0.0021	CcSEcCtD
Oxycodone—Hypoaesthesia—Temozolomide—brain cancer	0.00067	0.0021	CcSEcCtD
Oxycodone—Hallucination—Temozolomide—brain cancer	0.00067	0.0021	CcSEcCtD
Oxycodone—Pharyngitis—Temozolomide—brain cancer	0.000669	0.00209	CcSEcCtD
Oxycodone—Urinary tract disorder—Temozolomide—brain cancer	0.000665	0.00208	CcSEcCtD
Oxycodone—Oedema peripheral—Temozolomide—brain cancer	0.000664	0.00208	CcSEcCtD
Oxycodone—Bronchospasm—Etoposide—brain cancer	0.000663	0.00207	CcSEcCtD
Oxycodone—Connective tissue disorder—Temozolomide—brain cancer	0.000662	0.00207	CcSEcCtD
Oxycodone—Urethral disorder—Temozolomide—brain cancer	0.00066	0.00207	CcSEcCtD
Oxycodone—Hydromorphone—CYP2C9—brain cancer	0.00066	1	CrCbGaD
Oxycodone—Feeling abnormal—Procarbazine—brain cancer	0.000652	0.00204	CcSEcCtD
Oxycodone—Eye disorder—Carmustine—brain cancer	0.000652	0.00204	CcSEcCtD
Oxycodone—Convulsion—Hydroxyurea—brain cancer	0.00065	0.00203	CcSEcCtD
Oxycodone—Visual impairment—Temozolomide—brain cancer	0.000649	0.00203	CcSEcCtD
Oxycodone—CYP2D6—brainstem—brain cancer	0.000649	0.0162	CbGeAlD
Oxycodone—OPRM1—brain—brain cancer	0.000648	0.0162	CbGeAlD
Oxycodone—Gastrointestinal pain—Procarbazine—brain cancer	0.000647	0.00202	CcSEcCtD
Oxycodone—Flushing—Carmustine—brain cancer	0.000647	0.00202	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000635	0.00198	CcSEcCtD
Oxycodone—Discomfort—Hydroxyurea—brain cancer	0.000632	0.00197	CcSEcCtD
Oxycodone—Eye disorder—Temozolomide—brain cancer	0.00063	0.00197	CcSEcCtD
Oxycodone—Urticaria—Procarbazine—brain cancer	0.000629	0.00197	CcSEcCtD
Oxycodone—Tinnitus—Temozolomide—brain cancer	0.000628	0.00196	CcSEcCtD
Oxycodone—Body temperature increased—Procarbazine—brain cancer	0.000626	0.00196	CcSEcCtD
Oxycodone—Abdominal pain—Procarbazine—brain cancer	0.000626	0.00196	CcSEcCtD
Oxycodone—Cardiac disorder—Temozolomide—brain cancer	0.000625	0.00196	CcSEcCtD
Oxycodone—Flushing—Temozolomide—brain cancer	0.000625	0.00196	CcSEcCtD
Oxycodone—Oedema—Hydroxyurea—brain cancer	0.000613	0.00192	CcSEcCtD
Oxycodone—Angiopathy—Temozolomide—brain cancer	0.000611	0.00191	CcSEcCtD
Oxycodone—Mental disorder—Carmustine—brain cancer	0.000611	0.00191	CcSEcCtD
Oxycodone—Infection—Hydroxyurea—brain cancer	0.000609	0.0019	CcSEcCtD
Oxycodone—Immune system disorder—Temozolomide—brain cancer	0.000609	0.0019	CcSEcCtD
Oxycodone—Mediastinal disorder—Temozolomide—brain cancer	0.000607	0.0019	CcSEcCtD
Oxycodone—Malnutrition—Carmustine—brain cancer	0.000607	0.0019	CcSEcCtD
Oxycodone—Chills—Temozolomide—brain cancer	0.000605	0.00189	CcSEcCtD
Oxycodone—Pneumonia—Etoposide—brain cancer	0.000604	0.00189	CcSEcCtD
Oxycodone—Nervous system disorder—Hydroxyurea—brain cancer	0.000601	0.00188	CcSEcCtD
Oxycodone—Infestation—Etoposide—brain cancer	0.000601	0.00188	CcSEcCtD
Oxycodone—Infestation NOS—Etoposide—brain cancer	0.000601	0.00188	CcSEcCtD
Oxycodone—Skin disorder—Hydroxyurea—brain cancer	0.000595	0.00186	CcSEcCtD
Oxycodone—Mental disorder—Temozolomide—brain cancer	0.00059	0.00185	CcSEcCtD
Oxycodone—Back pain—Carmustine—brain cancer	0.000587	0.00184	CcSEcCtD
Oxycodone—Malnutrition—Temozolomide—brain cancer	0.000587	0.00183	CcSEcCtD
Oxycodone—Stomatitis—Etoposide—brain cancer	0.000585	0.00183	CcSEcCtD
Oxycodone—Anorexia—Hydroxyurea—brain cancer	0.000584	0.00183	CcSEcCtD
Oxycodone—Hypersensitivity—Procarbazine—brain cancer	0.000583	0.00182	CcSEcCtD
Oxycodone—CYP2D6—telencephalon—brain cancer	0.000576	0.0144	CbGeAlD
Oxycodone—Dysgeusia—Temozolomide—brain cancer	0.000574	0.0018	CcSEcCtD
Oxycodone—Tremor—Carmustine—brain cancer	0.000569	0.00178	CcSEcCtD
Oxycodone—Asthenia—Procarbazine—brain cancer	0.000568	0.00178	CcSEcCtD
Oxycodone—Hepatobiliary disease—Etoposide—brain cancer	0.000568	0.00178	CcSEcCtD
Oxycodone—Back pain—Temozolomide—brain cancer	0.000567	0.00177	CcSEcCtD
Oxycodone—Anaemia—Carmustine—brain cancer	0.000561	0.00175	CcSEcCtD
Oxycodone—Pruritus—Procarbazine—brain cancer	0.00056	0.00175	CcSEcCtD
Oxycodone—Agitation—Carmustine—brain cancer	0.000558	0.00174	CcSEcCtD
Oxycodone—Tremor—Temozolomide—brain cancer	0.000549	0.00172	CcSEcCtD
Oxycodone—Dyspnoea—Hydroxyurea—brain cancer	0.000546	0.00171	CcSEcCtD
Oxycodone—Somnolence—Hydroxyurea—brain cancer	0.000545	0.0017	CcSEcCtD
Oxycodone—Ill-defined disorder—Temozolomide—brain cancer	0.000544	0.0017	CcSEcCtD
Oxycodone—Leukopenia—Carmustine—brain cancer	0.000543	0.0017	CcSEcCtD
Oxycodone—Anaemia—Temozolomide—brain cancer	0.000542	0.0017	CcSEcCtD
Oxycodone—Diarrhoea—Procarbazine—brain cancer	0.000542	0.00169	CcSEcCtD
Oxycodone—Dyspepsia—Hydroxyurea—brain cancer	0.000539	0.00169	CcSEcCtD
Oxycodone—Agitation—Temozolomide—brain cancer	0.000539	0.00169	CcSEcCtD
Oxycodone—Hypoaesthesia—Etoposide—brain cancer	0.000536	0.00168	CcSEcCtD
Oxycodone—Angioedema—Temozolomide—brain cancer	0.000536	0.00168	CcSEcCtD
Oxycodone—Decreased appetite—Hydroxyurea—brain cancer	0.000533	0.00167	CcSEcCtD
Oxycodone—Urinary tract disorder—Etoposide—brain cancer	0.000532	0.00166	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000529	0.00165	CcSEcCtD
Oxycodone—Malaise—Temozolomide—brain cancer	0.000529	0.00165	CcSEcCtD
Oxycodone—Urethral disorder—Etoposide—brain cancer	0.000528	0.00165	CcSEcCtD
Oxycodone—Fatigue—Hydroxyurea—brain cancer	0.000528	0.00165	CcSEcCtD
Oxycodone—Vertigo—Temozolomide—brain cancer	0.000527	0.00165	CcSEcCtD
Oxycodone—Convulsion—Carmustine—brain cancer	0.000526	0.00164	CcSEcCtD
Oxycodone—Leukopenia—Temozolomide—brain cancer	0.000525	0.00164	CcSEcCtD
Oxycodone—Constipation—Hydroxyurea—brain cancer	0.000524	0.00164	CcSEcCtD
Oxycodone—Pain—Hydroxyurea—brain cancer	0.000524	0.00164	CcSEcCtD
Oxycodone—Dizziness—Procarbazine—brain cancer	0.000524	0.00164	CcSEcCtD
Oxycodone—Palpitations—Temozolomide—brain cancer	0.000518	0.00162	CcSEcCtD
Oxycodone—Myalgia—Carmustine—brain cancer	0.000517	0.00162	CcSEcCtD
Oxycodone—Chest pain—Carmustine—brain cancer	0.000517	0.00162	CcSEcCtD
Oxycodone—Anxiety—Carmustine—brain cancer	0.000515	0.00161	CcSEcCtD
Oxycodone—Cough—Temozolomide—brain cancer	0.000512	0.0016	CcSEcCtD
Oxycodone—Convulsion—Temozolomide—brain cancer	0.000508	0.00159	CcSEcCtD
Oxycodone—Feeling abnormal—Hydroxyurea—brain cancer	0.000505	0.00158	CcSEcCtD
Oxycodone—Eye disorder—Etoposide—brain cancer	0.000504	0.00158	CcSEcCtD
Oxycodone—Vomiting—Procarbazine—brain cancer	0.000503	0.00157	CcSEcCtD
Oxycodone—Cardiac disorder—Etoposide—brain cancer	0.0005	0.00156	CcSEcCtD
Oxycodone—Flushing—Etoposide—brain cancer	0.0005	0.00156	CcSEcCtD
Oxycodone—Confusional state—Carmustine—brain cancer	0.000499	0.00156	CcSEcCtD
Oxycodone—Myalgia—Temozolomide—brain cancer	0.000499	0.00156	CcSEcCtD
Oxycodone—Arthralgia—Temozolomide—brain cancer	0.000499	0.00156	CcSEcCtD
Oxycodone—Rash—Procarbazine—brain cancer	0.000499	0.00156	CcSEcCtD
Oxycodone—Dermatitis—Procarbazine—brain cancer	0.000499	0.00156	CcSEcCtD
Oxycodone—Anxiety—Temozolomide—brain cancer	0.000498	0.00156	CcSEcCtD
Oxycodone—Headache—Procarbazine—brain cancer	0.000496	0.00155	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000496	0.00155	CcSEcCtD
Oxycodone—Oedema—Carmustine—brain cancer	0.000495	0.00155	CcSEcCtD
Oxycodone—Discomfort—Temozolomide—brain cancer	0.000493	0.00154	CcSEcCtD
Oxycodone—Infection—Carmustine—brain cancer	0.000492	0.00154	CcSEcCtD
Oxycodone—CYP3A5—endocrine gland—brain cancer	0.000492	0.0123	CbGeAlD
Oxycodone—Angiopathy—Etoposide—brain cancer	0.000489	0.00153	CcSEcCtD
Oxycodone—Dry mouth—Temozolomide—brain cancer	0.000488	0.00153	CcSEcCtD
Oxycodone—Immune system disorder—Etoposide—brain cancer	0.000487	0.00152	CcSEcCtD
Oxycodone—Mediastinal disorder—Etoposide—brain cancer	0.000486	0.00152	CcSEcCtD
Oxycodone—Body temperature increased—Hydroxyurea—brain cancer	0.000484	0.00151	CcSEcCtD
Oxycodone—Chills—Etoposide—brain cancer	0.000484	0.00151	CcSEcCtD
Oxycodone—Tachycardia—Carmustine—brain cancer	0.000483	0.00151	CcSEcCtD
Oxycodone—Confusional state—Temozolomide—brain cancer	0.000483	0.00151	CcSEcCtD
Oxycodone—Anaphylactic shock—Temozolomide—brain cancer	0.000479	0.0015	CcSEcCtD
Oxycodone—Oedema—Temozolomide—brain cancer	0.000479	0.0015	CcSEcCtD
Oxycodone—Infection—Temozolomide—brain cancer	0.000476	0.00149	CcSEcCtD
Oxycodone—Anorexia—Carmustine—brain cancer	0.000472	0.00148	CcSEcCtD
Oxycodone—Nausea—Procarbazine—brain cancer	0.00047	0.00147	CcSEcCtD
Oxycodone—Nervous system disorder—Temozolomide—brain cancer	0.000469	0.00147	CcSEcCtD
Oxycodone—Skin disorder—Temozolomide—brain cancer	0.000465	0.00145	CcSEcCtD
Oxycodone—Hypotension—Carmustine—brain cancer	0.000463	0.00145	CcSEcCtD
Oxycodone—Hyperhidrosis—Temozolomide—brain cancer	0.000463	0.00145	CcSEcCtD
Oxycodone—Dysgeusia—Etoposide—brain cancer	0.00046	0.00144	CcSEcCtD
Oxycodone—Anorexia—Temozolomide—brain cancer	0.000456	0.00143	CcSEcCtD
Oxycodone—Back pain—Etoposide—brain cancer	0.000454	0.00142	CcSEcCtD
Oxycodone—Hypersensitivity—Hydroxyurea—brain cancer	0.000451	0.00141	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Carmustine—brain cancer	0.000451	0.00141	CcSEcCtD
Oxycodone—Muscle spasms—Etoposide—brain cancer	0.000451	0.00141	CcSEcCtD
Oxycodone—Insomnia—Carmustine—brain cancer	0.000448	0.0014	CcSEcCtD
Oxycodone—Paraesthesia—Carmustine—brain cancer	0.000445	0.00139	CcSEcCtD
Oxycodone—Dyspnoea—Carmustine—brain cancer	0.000442	0.00138	CcSEcCtD
Oxycodone—Somnolence—Carmustine—brain cancer	0.00044	0.00138	CcSEcCtD
Oxycodone—Asthenia—Hydroxyurea—brain cancer	0.00044	0.00137	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000436	0.00136	CcSEcCtD
Oxycodone—Ill-defined disorder—Etoposide—brain cancer	0.000435	0.00136	CcSEcCtD
Oxycodone—Anaemia—Etoposide—brain cancer	0.000434	0.00136	CcSEcCtD
Oxycodone—Insomnia—Temozolomide—brain cancer	0.000433	0.00135	CcSEcCtD
Oxycodone—Decreased appetite—Carmustine—brain cancer	0.000431	0.00135	CcSEcCtD
Oxycodone—Paraesthesia—Temozolomide—brain cancer	0.00043	0.00134	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Carmustine—brain cancer	0.000428	0.00134	CcSEcCtD
Oxycodone—Dyspnoea—Temozolomide—brain cancer	0.000427	0.00133	CcSEcCtD
Oxycodone—Somnolence—Temozolomide—brain cancer	0.000426	0.00133	CcSEcCtD
Oxycodone—Pain—Carmustine—brain cancer	0.000424	0.00132	CcSEcCtD
Oxycodone—Constipation—Carmustine—brain cancer	0.000424	0.00132	CcSEcCtD
Oxycodone—Malaise—Etoposide—brain cancer	0.000423	0.00132	CcSEcCtD
Oxycodone—Vertigo—Etoposide—brain cancer	0.000422	0.00132	CcSEcCtD
Oxycodone—Dyspepsia—Temozolomide—brain cancer	0.000421	0.00132	CcSEcCtD
Oxycodone—Leukopenia—Etoposide—brain cancer	0.00042	0.00131	CcSEcCtD
Oxycodone—Diarrhoea—Hydroxyurea—brain cancer	0.000419	0.00131	CcSEcCtD
Oxycodone—Decreased appetite—Temozolomide—brain cancer	0.000416	0.0013	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Temozolomide—brain cancer	0.000413	0.00129	CcSEcCtD
Oxycodone—Fatigue—Temozolomide—brain cancer	0.000413	0.00129	CcSEcCtD
Oxycodone—Loss of consciousness—Etoposide—brain cancer	0.000412	0.00129	CcSEcCtD
Oxycodone—Cough—Etoposide—brain cancer	0.00041	0.00128	CcSEcCtD
Oxycodone—Constipation—Temozolomide—brain cancer	0.000409	0.00128	CcSEcCtD
Oxycodone—Pain—Temozolomide—brain cancer	0.000409	0.00128	CcSEcCtD
Oxycodone—Feeling abnormal—Carmustine—brain cancer	0.000408	0.00128	CcSEcCtD
Oxycodone—Convulsion—Etoposide—brain cancer	0.000407	0.00127	CcSEcCtD
Oxycodone—Dizziness—Hydroxyurea—brain cancer	0.000405	0.00127	CcSEcCtD
Oxycodone—Gastrointestinal pain—Carmustine—brain cancer	0.000405	0.00127	CcSEcCtD
Oxycodone—Chest pain—Etoposide—brain cancer	0.0004	0.00125	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000397	0.00124	CcSEcCtD
Oxycodone—Discomfort—Etoposide—brain cancer	0.000395	0.00123	CcSEcCtD
Oxycodone—Feeling abnormal—Temozolomide—brain cancer	0.000394	0.00123	CcSEcCtD
Oxycodone—Abdominal pain—Carmustine—brain cancer	0.000392	0.00122	CcSEcCtD
Oxycodone—Body temperature increased—Carmustine—brain cancer	0.000392	0.00122	CcSEcCtD
Oxycodone—Gastrointestinal pain—Temozolomide—brain cancer	0.000391	0.00122	CcSEcCtD
Oxycodone—Vomiting—Hydroxyurea—brain cancer	0.00039	0.00122	CcSEcCtD
Oxycodone—Rash—Hydroxyurea—brain cancer	0.000386	0.00121	CcSEcCtD
Oxycodone—Confusional state—Etoposide—brain cancer	0.000386	0.00121	CcSEcCtD
Oxycodone—Dermatitis—Hydroxyurea—brain cancer	0.000386	0.00121	CcSEcCtD
Oxycodone—Headache—Hydroxyurea—brain cancer	0.000384	0.0012	CcSEcCtD
Oxycodone—Anaphylactic shock—Etoposide—brain cancer	0.000383	0.0012	CcSEcCtD
Oxycodone—Infection—Etoposide—brain cancer	0.000381	0.00119	CcSEcCtD
Oxycodone—Urticaria—Temozolomide—brain cancer	0.00038	0.00119	CcSEcCtD
Oxycodone—Body temperature increased—Temozolomide—brain cancer	0.000378	0.00118	CcSEcCtD
Oxycodone—Abdominal pain—Temozolomide—brain cancer	0.000378	0.00118	CcSEcCtD
Oxycodone—Tachycardia—Etoposide—brain cancer	0.000374	0.00117	CcSEcCtD
Oxycodone—Skin disorder—Etoposide—brain cancer	0.000372	0.00116	CcSEcCtD
Oxycodone—Hyperhidrosis—Etoposide—brain cancer	0.00037	0.00116	CcSEcCtD
Oxycodone—CYP3A4—endocrine gland—brain cancer	0.000369	0.0092	CbGeAlD
Oxycodone—Anorexia—Etoposide—brain cancer	0.000365	0.00114	CcSEcCtD
Oxycodone—Hypersensitivity—Carmustine—brain cancer	0.000365	0.00114	CcSEcCtD
Oxycodone—Nausea—Hydroxyurea—brain cancer	0.000364	0.00114	CcSEcCtD
Oxycodone—CYP2D6—endocrine gland—brain cancer	0.000363	0.00906	CbGeAlD
Oxycodone—CYP2D6—head—brain cancer	0.000359	0.00894	CbGeAlD
Oxycodone—Hypotension—Etoposide—brain cancer	0.000358	0.00112	CcSEcCtD
Oxycodone—Asthenia—Carmustine—brain cancer	0.000355	0.00111	CcSEcCtD
Oxycodone—Hypersensitivity—Temozolomide—brain cancer	0.000353	0.0011	CcSEcCtD
Oxycodone—Paraesthesia—Etoposide—brain cancer	0.000344	0.00108	CcSEcCtD
Oxycodone—Asthenia—Temozolomide—brain cancer	0.000343	0.00107	CcSEcCtD
Oxycodone—Dyspnoea—Etoposide—brain cancer	0.000341	0.00107	CcSEcCtD
Oxycodone—Somnolence—Etoposide—brain cancer	0.000341	0.00106	CcSEcCtD
Oxycodone—Diarrhoea—Carmustine—brain cancer	0.000339	0.00106	CcSEcCtD
Oxycodone—Pruritus—Temozolomide—brain cancer	0.000339	0.00106	CcSEcCtD
Oxycodone—Decreased appetite—Etoposide—brain cancer	0.000333	0.00104	CcSEcCtD
Oxycodone—CYP3A4—central nervous system—brain cancer	0.000333	0.00829	CbGeAlD
Oxycodone—Gastrointestinal disorder—Etoposide—brain cancer	0.000331	0.00103	CcSEcCtD
Oxycodone—Fatigue—Etoposide—brain cancer	0.00033	0.00103	CcSEcCtD
Oxycodone—Dizziness—Carmustine—brain cancer	0.000328	0.00102	CcSEcCtD
Oxycodone—Pain—Etoposide—brain cancer	0.000328	0.00102	CcSEcCtD
Oxycodone—Constipation—Etoposide—brain cancer	0.000328	0.00102	CcSEcCtD
Oxycodone—Diarrhoea—Temozolomide—brain cancer	0.000328	0.00102	CcSEcCtD
Oxycodone—CYP2D6—central nervous system—brain cancer	0.000327	0.00816	CbGeAlD
Oxycodone—CYP2D6—cerebellum—brain cancer	0.00032	0.00798	CbGeAlD
Oxycodone—Dizziness—Temozolomide—brain cancer	0.000317	0.00099	CcSEcCtD
Oxycodone—Feeling abnormal—Etoposide—brain cancer	0.000316	0.000987	CcSEcCtD
Oxycodone—Vomiting—Carmustine—brain cancer	0.000315	0.000985	CcSEcCtD
Oxycodone—Gastrointestinal pain—Etoposide—brain cancer	0.000313	0.000979	CcSEcCtD
Oxycodone—Rash—Carmustine—brain cancer	0.000312	0.000977	CcSEcCtD
Oxycodone—Dermatitis—Carmustine—brain cancer	0.000312	0.000976	CcSEcCtD
Oxycodone—Headache—Carmustine—brain cancer	0.00031	0.00097	CcSEcCtD
Oxycodone—Vomiting—Temozolomide—brain cancer	0.000304	0.000952	CcSEcCtD
Oxycodone—Urticaria—Etoposide—brain cancer	0.000304	0.000951	CcSEcCtD
Oxycodone—Body temperature increased—Etoposide—brain cancer	0.000303	0.000947	CcSEcCtD
Oxycodone—Abdominal pain—Etoposide—brain cancer	0.000303	0.000947	CcSEcCtD
Oxycodone—Rash—Temozolomide—brain cancer	0.000302	0.000944	CcSEcCtD
Oxycodone—Dermatitis—Temozolomide—brain cancer	0.000302	0.000943	CcSEcCtD
Oxycodone—Headache—Temozolomide—brain cancer	0.0003	0.000938	CcSEcCtD
Oxycodone—Nausea—Carmustine—brain cancer	0.000294	0.00092	CcSEcCtD
Oxycodone—Nausea—Temozolomide—brain cancer	0.000284	0.000889	CcSEcCtD
Oxycodone—Hypersensitivity—Etoposide—brain cancer	0.000282	0.000882	CcSEcCtD
Oxycodone—Asthenia—Etoposide—brain cancer	0.000275	0.000859	CcSEcCtD
Oxycodone—Pruritus—Etoposide—brain cancer	0.000271	0.000847	CcSEcCtD
Oxycodone—Diarrhoea—Etoposide—brain cancer	0.000262	0.000819	CcSEcCtD
Oxycodone—CYP2D6—brain—brain cancer	0.00026	0.00648	CbGeAlD
Oxycodone—Dizziness—Etoposide—brain cancer	0.000253	0.000792	CcSEcCtD
Oxycodone—Vomiting—Etoposide—brain cancer	0.000244	0.000762	CcSEcCtD
Oxycodone—Rash—Etoposide—brain cancer	0.000242	0.000755	CcSEcCtD
Oxycodone—Dermatitis—Etoposide—brain cancer	0.000241	0.000754	CcSEcCtD
Oxycodone—Headache—Etoposide—brain cancer	0.00024	0.00075	CcSEcCtD
Oxycodone—Nausea—Etoposide—brain cancer	0.000228	0.000711	CcSEcCtD
Oxycodone—CYP3A7—Xenobiotics—CYP2C9—brain cancer	4.74e-05	0.0601	CbGpPWpGaD
Oxycodone—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	3.93e-05	0.0498	CbGpPWpGaD
Oxycodone—CYP3A5—Xenobiotics—CYP2C9—brain cancer	3.43e-05	0.0434	CbGpPWpGaD
Oxycodone—CYP3A5—Tamoxifen metabolism—CYP2C9—brain cancer	3.3e-05	0.0418	CbGpPWpGaD
Oxycodone—CYP2D6—Xenobiotics—CYP2C9—brain cancer	2.44e-05	0.0309	CbGpPWpGaD
Oxycodone—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	2.35e-05	0.0298	CbGpPWpGaD
Oxycodone—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	2.34e-05	0.0297	CbGpPWpGaD
Oxycodone—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	1.97e-05	0.0249	CbGpPWpGaD
Oxycodone—CYP3A7—Oxidation by Cytochrome P450—CYP2C9—brain cancer	1.94e-05	0.0246	CbGpPWpGaD
Oxycodone—CYP3A7—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	1.6e-05	0.0202	CbGpPWpGaD
Oxycodone—CYP3A4—Xenobiotics—CYP2C9—brain cancer	1.59e-05	0.0202	CbGpPWpGaD
Oxycodone—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	1.53e-05	0.0194	CbGpPWpGaD
Oxycodone—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	1.42e-05	0.018	CbGpPWpGaD
Oxycodone—CYP3A5—Oxidation by Cytochrome P450—CYP2C9—brain cancer	1.4e-05	0.0178	CbGpPWpGaD
Oxycodone—CYP3A5—Irinotecan Pathway—APC—brain cancer	1.21e-05	0.0153	CbGpPWpGaD
Oxycodone—CYP3A5—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	1.15e-05	0.0146	CbGpPWpGaD
Oxycodone—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	1.09e-05	0.0139	CbGpPWpGaD
Oxycodone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	1.04e-05	0.0132	CbGpPWpGaD
Oxycodone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	1.01e-05	0.0128	CbGpPWpGaD
Oxycodone—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	9.99e-06	0.0127	CbGpPWpGaD
Oxycodone—CYP3A7—Biological oxidations—CYP2C9—brain cancer	8.48e-06	0.0107	CbGpPWpGaD
Oxycodone—CYP3A7—Metapathway biotransformation—CYP2C9—brain cancer	8.36e-06	0.0106	CbGpPWpGaD
Oxycodone—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	8.2e-06	0.0104	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—PTCH2—brain cancer	7.04e-06	0.00892	CbGpPWpGaD
Oxycodone—OPRM1—TCR Signaling Pathway—VAV1—brain cancer	6.91e-06	0.00875	CbGpPWpGaD
Oxycodone—OPRM1—IL4-mediated signaling events—IRS2—brain cancer	6.69e-06	0.00848	CbGpPWpGaD
Oxycodone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	6.62e-06	0.00838	CbGpPWpGaD
Oxycodone—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	6.53e-06	0.00827	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—OR4C12—brain cancer	6.17e-06	0.00782	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—OR14C36—brain cancer	6.17e-06	0.00782	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—PTCH2—brain cancer	6.17e-06	0.00782	CbGpPWpGaD
Oxycodone—CYP3A5—Biological oxidations—CYP2C9—brain cancer	6.13e-06	0.00776	CbGpPWpGaD
Oxycodone—CYP3A5—Metapathway biotransformation—CYP2C9—brain cancer	6.04e-06	0.00766	CbGpPWpGaD
Oxycodone—CYP3A4—Irinotecan Pathway—APC—brain cancer	5.62e-06	0.00712	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—OR4C12—brain cancer	5.61e-06	0.0071	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—OR14C36—brain cancer	5.61e-06	0.0071	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—OR4C12—brain cancer	5.41e-06	0.00686	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—OR14C36—brain cancer	5.41e-06	0.00686	CbGpPWpGaD
Oxycodone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	5.36e-06	0.00679	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—PTCH2—brain cancer	5.22e-06	0.00661	CbGpPWpGaD
Oxycodone—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	4.98e-06	0.00631	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—OR4C12—brain cancer	4.92e-06	0.00623	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—OR14C36—brain cancer	4.92e-06	0.00623	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—OR14C36—brain cancer	4.57e-06	0.0058	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—OR4C12—brain cancer	4.57e-06	0.0058	CbGpPWpGaD
Oxycodone—CYP2D6—Biological oxidations—CYP2C9—brain cancer	4.36e-06	0.00552	CbGpPWpGaD
Oxycodone—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	4.3e-06	0.00544	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—OR4C12—brain cancer	4.15e-06	0.00526	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—OR14C36—brain cancer	4.15e-06	0.00526	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—SHH—brain cancer	3.63e-06	0.00459	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—PTCH2—brain cancer	3.61e-06	0.00458	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—PTCH1—brain cancer	3.44e-06	0.00435	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—SMO—brain cancer	3.44e-06	0.00435	CbGpPWpGaD
Oxycodone—OPRM1—TCR Signaling Pathway—RELA—brain cancer	3.43e-06	0.00434	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—OR4C12—brain cancer	3.31e-06	0.00419	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—OR14C36—brain cancer	3.31e-06	0.00419	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—SHH—brain cancer	3.18e-06	0.00403	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—PTCH2—brain cancer	3.17e-06	0.00401	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—ABR—brain cancer	3.12e-06	0.00395	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—SMO—brain cancer	3.01e-06	0.00382	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—PTCH1—brain cancer	3.01e-06	0.00382	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—OR14C36—brain cancer	2.9e-06	0.00368	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—OR4C12—brain cancer	2.9e-06	0.00368	CbGpPWpGaD
Oxycodone—CYP3A4—Biological oxidations—CYP2C9—brain cancer	2.85e-06	0.00361	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—ABR—brain cancer	2.83e-06	0.00359	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—DTX2—brain cancer	2.82e-06	0.00357	CbGpPWpGaD
Oxycodone—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	2.81e-06	0.00356	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—ABR—brain cancer	2.74e-06	0.00347	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—SHH—brain cancer	2.69e-06	0.0034	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—PTCH2—brain cancer	2.68e-06	0.00339	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—PTCH1—brain cancer	2.55e-06	0.00323	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—SMO—brain cancer	2.55e-06	0.00323	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—ABR—brain cancer	2.49e-06	0.00315	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—DTX2—brain cancer	2.47e-06	0.00313	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—OR4C12—brain cancer	2.45e-06	0.00311	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—OR14C36—brain cancer	2.45e-06	0.00311	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—ABR—brain cancer	2.31e-06	0.00293	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PTCH2—brain cancer	2.13e-06	0.0027	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—ABR—brain cancer	2.1e-06	0.00266	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—DTX2—brain cancer	2.09e-06	0.00264	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—HES5—brain cancer	2.07e-06	0.00262	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—STRADA—brain cancer	2.01e-06	0.00254	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—TRPC6—brain cancer	1.98e-06	0.0025	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PTCH2—brain cancer	1.87e-06	0.00237	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—SHH—brain cancer	1.86e-06	0.00236	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—HES5—brain cancer	1.81e-06	0.0023	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—TRPC6—brain cancer	1.79e-06	0.00227	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—SMO—brain cancer	1.76e-06	0.00223	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—PTCH1—brain cancer	1.76e-06	0.00223	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—STRADA—brain cancer	1.76e-06	0.00223	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—TRPC6—brain cancer	1.73e-06	0.00219	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—ABR—brain cancer	1.67e-06	0.00212	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—SHH—brain cancer	1.63e-06	0.00207	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—GLI2—brain cancer	1.62e-06	0.00205	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PTCH2—brain cancer	1.58e-06	0.002	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—TRPC6—brain cancer	1.57e-06	0.00199	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—SMO—brain cancer	1.55e-06	0.00196	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—PTCH1—brain cancer	1.55e-06	0.00196	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—HES5—brain cancer	1.53e-06	0.00194	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—GLI1—brain cancer	1.52e-06	0.00193	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—STRADA—brain cancer	1.49e-06	0.00188	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—VAV1—brain cancer	1.48e-06	0.00188	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—ABR—brain cancer	1.47e-06	0.00186	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—TRPC6—brain cancer	1.46e-06	0.00186	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—CYP2C9—brain cancer	1.45e-06	0.00184	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—SUFU—brain cancer	1.44e-06	0.00183	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—GLI2—brain cancer	1.42e-06	0.0018	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—GFAP—brain cancer	1.39e-06	0.00176	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—SHH—brain cancer	1.38e-06	0.00175	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—VAV1—brain cancer	1.34e-06	0.0017	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—GLI1—brain cancer	1.33e-06	0.00169	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—TRPC6—brain cancer	1.33e-06	0.00168	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—HEY1—brain cancer	1.32e-06	0.00167	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—PTCH1—brain cancer	1.31e-06	0.00166	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—SMO—brain cancer	1.31e-06	0.00166	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—VAV1—brain cancer	1.3e-06	0.00164	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—DLL1—brain cancer	1.29e-06	0.00164	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—SUFU—brain cancer	1.26e-06	0.0016	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—ABR—brain cancer	1.24e-06	0.00157	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—BSG—brain cancer	1.23e-06	0.00156	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—GFAP—brain cancer	1.22e-06	0.00154	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—GLI2—brain cancer	1.2e-06	0.00152	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—VAV1—brain cancer	1.18e-06	0.00149	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—HEY1—brain cancer	1.16e-06	0.00146	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—DLL1—brain cancer	1.13e-06	0.00144	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—GLI1—brain cancer	1.13e-06	0.00143	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—SHH—brain cancer	1.1e-06	0.00139	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—VAV1—brain cancer	1.1e-06	0.00139	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—SUFU—brain cancer	1.07e-06	0.00135	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—IDH1—brain cancer	1.06e-06	0.00134	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—TRPC6—brain cancer	1.06e-06	0.00134	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CYP2C9—brain cancer	1.05e-06	0.00133	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PTCH1—brain cancer	1.04e-06	0.00132	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—SMO—brain cancer	1.04e-06	0.00132	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—GFAP—brain cancer	1.03e-06	0.00131	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—VAV1—brain cancer	9.96e-07	0.00126	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—HEY1—brain cancer	9.77e-07	0.00124	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—SHH—brain cancer	9.64e-07	0.00122	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—DLL1—brain cancer	9.58e-07	0.00121	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—PIK3CG—brain cancer	9.4e-07	0.00119	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—TRPC6—brain cancer	9.29e-07	0.00118	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PTCH1—brain cancer	9.14e-07	0.00116	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—SMO—brain cancer	9.14e-07	0.00116	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—BSG—brain cancer	8.91e-07	0.00113	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—PIK3CG—brain cancer	8.54e-07	0.00108	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—ENO2—brain cancer	8.38e-07	0.00106	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—NOTCH2—brain cancer	8.33e-07	0.00106	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—PIK3CG—brain cancer	8.24e-07	0.00104	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—SHH—brain cancer	8.15e-07	0.00103	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—VAV1—brain cancer	7.94e-07	0.00101	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TRPC6—brain cancer	7.86e-07	0.000995	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PTCH1—brain cancer	7.72e-07	0.000978	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—SMO—brain cancer	7.72e-07	0.000978	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—IDH1—brain cancer	7.66e-07	0.000971	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—PIK3CG—brain cancer	7.49e-07	0.000948	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CYP2C9—brain cancer	7.45e-07	0.000944	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—NOTCH2—brain cancer	7.31e-07	0.000925	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—PIK3CG—brain cancer	6.97e-07	0.000883	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—VAV1—brain cancer	6.96e-07	0.000882	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—HES1—brain cancer	6.83e-07	0.000865	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—IL2—brain cancer	6.62e-07	0.000838	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PDGFRA—brain cancer	6.5e-07	0.000824	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—BSG—brain cancer	6.34e-07	0.000803	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—PIK3CG—brain cancer	6.33e-07	0.000801	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—SPP1—brain cancer	6.31e-07	0.0008	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NOTCH2—brain cancer	6.17e-07	0.000782	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—ENO2—brain cancer	6.06e-07	0.000767	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—IL2—brain cancer	6.01e-07	0.000761	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—HES1—brain cancer	5.99e-07	0.000759	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—VAV1—brain cancer	5.89e-07	0.000746	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—IL2—brain cancer	5.8e-07	0.000735	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IRS2—brain cancer	5.71e-07	0.000723	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PDGFRA—brain cancer	5.7e-07	0.000722	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—SPP1—brain cancer	5.54e-07	0.000701	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—IDH1—brain cancer	5.45e-07	0.00069	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—IL2—brain cancer	5.27e-07	0.000667	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—HES1—brain cancer	5.06e-07	0.000641	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PIK3CG—brain cancer	5.04e-07	0.000639	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—APC—brain cancer	5.04e-07	0.000639	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IRS2—brain cancer	5.01e-07	0.000634	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—IL2—brain cancer	4.9e-07	0.000621	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP2C9—brain cancer	4.87e-07	0.000617	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PDGFRA—brain cancer	4.82e-07	0.000611	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—SPP1—brain cancer	4.68e-07	0.000593	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—EGFR—brain cancer	4.59e-07	0.000582	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—IL2—brain cancer	4.45e-07	0.000564	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PIK3CG—brain cancer	4.42e-07	0.00056	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—APC—brain cancer	4.42e-07	0.00056	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ENO2—brain cancer	4.31e-07	0.000546	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IRS2—brain cancer	4.23e-07	0.000536	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—BSG—brain cancer	4.14e-07	0.000525	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—EGFR—brain cancer	4.03e-07	0.00051	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—RELA—brain cancer	3.94e-07	0.000499	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—ERBB2—brain cancer	3.92e-07	0.000496	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PIK3CG—brain cancer	3.84e-07	0.000487	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PIK3CG—brain cancer	3.74e-07	0.000473	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—APC—brain cancer	3.74e-07	0.000473	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—IDH1—brain cancer	3.56e-07	0.000451	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IL2—brain cancer	3.55e-07	0.00045	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CCND1—brain cancer	3.46e-07	0.000438	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—RELA—brain cancer	3.46e-07	0.000438	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—ERBB2—brain cancer	3.43e-07	0.000435	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CTNNB1—brain cancer	3.43e-07	0.000434	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—EGFR—brain cancer	3.4e-07	0.000431	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IL2—brain cancer	3.11e-07	0.000394	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CCND1—brain cancer	3.03e-07	0.000384	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—VEGFA—brain cancer	3.02e-07	0.000382	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CTNNB1—brain cancer	3e-07	0.000381	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—STAT3—brain cancer	2.99e-07	0.000378	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—RELA—brain cancer	2.92e-07	0.00037	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—ERBB2—brain cancer	2.9e-07	0.000368	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ENO2—brain cancer	2.82e-07	0.000357	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PIK3CG—brain cancer	2.78e-07	0.000352	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MYC—brain cancer	2.77e-07	0.000352	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—EGFR—brain cancer	2.71e-07	0.000344	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—VEGFA—brain cancer	2.64e-07	0.000335	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IL2—brain cancer	2.63e-07	0.000333	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—STAT3—brain cancer	2.62e-07	0.000332	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CCND1—brain cancer	2.56e-07	0.000325	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CTNNB1—brain cancer	2.54e-07	0.000322	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MYC—brain cancer	2.43e-07	0.000308	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—EGFR—brain cancer	2.38e-07	0.000301	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—TP53—brain cancer	2.28e-07	0.000289	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—VEGFA—brain cancer	2.23e-07	0.000283	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—STAT3—brain cancer	2.21e-07	0.00028	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MYC—brain cancer	2.06e-07	0.000261	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—EGFR—brain cancer	2.01e-07	0.000255	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—TP53—brain cancer	2e-07	0.000253	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PIK3CG—brain cancer	1.98e-07	0.00025	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TP53—brain cancer	1.69e-07	0.000214	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PIK3CG—brain cancer	1.29e-07	0.000164	CbGpPWpGaD
